Patricia Morris, NP

NPI: 1306930524
Total Payments
$28,914
2024 Payments
$12,343
Companies
13
Transactions
92

Payment Breakdown by Category

Other$18,069 (62.5%)
Travel$8,334 (28.8%)
Food & Beverage$2,511 (8.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $17,815 17 61.6%
Travel and Lodging $8,334 24 28.8%
Food and Beverage $2,511 49 8.7%
Honoraria $254.19 2 0.9%

Top Paying Companies

Company Total Records Latest Year
Stemline Therapeutics Inc. $28,233 64 $0 (2024)
Novartis Pharmaceuticals Corporation $194.49 7 $0 (2024)
Daiichi Sankyo Inc. $93.70 4 $0 (2024)
Merck Sharp & Dohme LLC $79.34 3 $0 (2024)
Eisai Inc. $56.85 3 $0 (2024)
AstraZeneca Pharmaceuticals LP $49.38 2 $0 (2024)
Pharmacyclics LLC, An AbbVie Company $46.03 2 $0 (2023)
Gilead Sciences, Inc. $45.27 2 $0 (2024)
PharmaEssentia USA Corporation $32.46 1 $0 (2023)
Deciphera Pharmaceuticals Inc. $22.34 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $12,343 46 Stemline Therapeutics Inc. ($11,794)
2023 $16,570 46 Stemline Therapeutics Inc. ($16,438)

All Payment Transactions

92 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
11/27/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $31.91 General
Category: Oncology
10/21/2024 Stemline Therapeutics Inc. Orserdu (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $165.00 General
Category: Oncology
10/17/2024 Stemline Therapeutics Inc. Orserdu (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $880.00 General
Category: Oncology
10/17/2024 Stemline Therapeutics Inc. Orserdu (Drug) Food and Beverage In-kind items and services $119.20 General
Category: Oncology
09/23/2024 Stemline Therapeutics Inc. Orserdu (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,320.00 General
Category: Oncology
09/23/2024 Stemline Therapeutics Inc. Orserdu (Drug) Travel and Lodging In-kind items and services $908.22 General
Category: Oncology
09/23/2024 Stemline Therapeutics Inc. Orserdu (Drug) Travel and Lodging In-kind items and services $315.45 General
Category: Oncology
09/23/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $29.36 General
Category: ONCOLOGY
09/19/2024 Stemline Therapeutics Inc. Orserdu (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,320.00 General
Category: Oncology
09/19/2024 Stemline Therapeutics Inc. Orserdu (Drug) Travel and Lodging In-kind items and services $647.95 General
Category: Oncology
09/19/2024 Stemline Therapeutics Inc. Orserdu (Drug) Travel and Lodging In-kind items and services $369.73 General
Category: Oncology
09/19/2024 Stemline Therapeutics Inc. Orserdu (Drug) Travel and Lodging In-kind items and services $278.60 General
Category: Oncology
09/19/2024 Stemline Therapeutics Inc. Orserdu (Drug) Food and Beverage In-kind items and services $99.75 General
Category: Oncology
09/19/2024 Stemline Therapeutics Inc. Orserdu (Drug) Travel and Lodging Cash or cash equivalent $60.00 General
Category: Oncology
09/19/2024 Stemline Therapeutics Inc. Orserdu (Drug) Food and Beverage Cash or cash equivalent $13.46 General
Category: Oncology
09/18/2024 Novartis Pharmaceuticals Corporation MEKINIST (Drug) Food and Beverage In-kind items and services $26.74 General
Category: Oncology
09/05/2024 Stemline Therapeutics Inc. Orserdu (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $660.00 General
Category: Oncology
08/28/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $28.18 General
Category: Oncology
08/22/2024 Stemline Therapeutics Inc. Orserdu (Drug) Food and Beverage In-kind items and services $113.81 General
Category: Oncology
07/08/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $28.71 General
Category: Oncology
06/12/2024 Lilly USA, LLC VERZENIO (Drug), RETEVMO, JAYPIRCA Food and Beverage In-kind items and services $22.00 General
Category: Oncology
05/29/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $34.14 General
Category: Oncology
05/28/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $23.75 General
Category: Oncology
05/21/2024 Janssen Biotech, Inc. RYBREVANT (Drug) Food and Beverage In-kind items and services $17.95 General
Category: Oncology
05/15/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $29.94 General
Category: Oncology

About Patricia Morris, NP

Patricia Morris, NP is a Nurse Practitioner healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306930524.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patricia Morris, NP has received a total of $28,914 in payments from pharmaceutical and medical device companies, with $12,343 received in 2024. These payments were reported across 92 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($17,815).

Practice Information

  • Specialty Nurse Practitioner
  • Location Nashville, TN
  • Active Since 10/03/2006
  • Last Updated 06/08/2012
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1306930524

Products in Payments

  • Orserdu (Drug) $28,233
  • KISQALI (Drug) $154.82
  • Enhertu (Drug) $63.80
  • Lenvima (Drug) $56.85
  • IMBRUVICA (Drug) $46.03
  • BESREMI (Drug) $32.46
  • KEYTRUDA (Biological) $31.37
  • CALQUENCE (Drug) $29.94
  • INJECTAFER (Drug) $29.90
  • MEKINIST (Drug) $26.74
  • QINLOCK (Drug) $22.34
  • VERZENIO (Drug) $22.00
  • Trelstar (Drug) $21.32
  • RYBREVANT (Drug) $17.95
  • PLUVICTO (Drug) $12.93

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Nashville